HOME >> BIOLOGY >> NEWS
Studies offer data on potential impact of Reminyl on caregiver 'burden' in Alzheimer's disease

Nice, France 13 SEPTEMBER 2001 Reminyl (galantamine) the newest medication approved to treat mild to moderate Alzheimers disease can ease the burden on family caregivers by reducing the amount of time required for supervision and assistance, as well as by alleviating the stress associated with these responsibilities, suggest data presented today at the Tenth Congress of the International Psychogeriatric Association (IPA).

One of the key characteristics of Alzheimers disease is the serious impact it has not only on persons with the illness, but also on their family caregivers, explains Prof. Gordon Wilcock, one of the lead authors of the research and professor in the Department of Care of the Elderly at Frenchay Hospital at the United Kingdom's University of Bristol. If a treatment can simultaneously benefit both of these groups, it would help to dispel the myth that Alzheimer's inevitably ends the productive lives of all involved. In addition, since the behavior of the patient, the time spent providing care and the overall burden on the family are significant factors in the decision to commit someone to a full-time-care facility, effective treatment with a medication like Reminyl may delay institutionalisation, which would have a positive economic impact."

Currently, it is estimated that as many as 17 million to 25 million people worldwide have Alzheimers disease a progressive loss of cognitive ability (thinking, remembering and reasoning) so severe that it interferes with an individuals ability to function and eventually leads to death.

Saving Caregiver Time

There were several research presentations at the IPA meeting this week that assessed the impact of Reminyl treatment on patient functioning by exploring the resulting impact on time required of family caregivers. One of these was an analysis led by Dr. Wilcock, which focused on the time caregivers spent supervising their family members or assisting them with activities of da
'"/>

Contact: Andrew Cooper
andrew.cooper@ketchum.com
44-020-7611-3859
Ketchum
13-Sep-2001


Page: 1 2 3 4

Related biology news :

1. Monkey business: Studies show tiny callimicos have unusual characteristics
2. Studies show success of Mectizan partnerships
3. Studies offer new insight into HIV vaccine development
4. Studies suggest brain injury results from developmental exposure to alcohol, anesthesia, and lead
5. Studies show preventive value of food supplements
6. Studies probe rapid evolution of Chinese tallow trees
7. Studies of rare blood syndrome yield novel route to cancer
8. Studies dispute ultraviolet effect on amphibian population declines
9. Studies of spiders silk reveal unusual strength
10. Studies of genes in mice and common worm may accelerate research on blood diseases, cancers
11. Studies: Floyd, other major hurricanes of 99 caused significant changes in nations largest lagoonal estuary

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives ... the award for Excellence in Volunteer Experience from US2020. , US2020’s mission is ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
Cached News: